home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

A.Vogel (Biohorma B.V.)

SHARESHARESHARE
Biohorma BV is the largest producer of phytotherapeutic and homeopathic medicines and health products in the Benelux countries, known under the brand name A.Vogel.
SHARESHARESHARE

RELATED NEWS


Studies have repeatedly linked maternal smoking during pregnancy with reduced sperm counts in male offspring. Now a research team at Lund University in Sweden has discovered that, independently of nicotine exposure from the mother, men whose fathers smoked at the time of pregnancy had half as many sperms as those with non-smoking fathers. The study was conducted on 104 Swedish men aged between 17 and 20. Once the researchers had adjusted for the mother's own exposure to nicotine, socioeconom...

READ MORE

In the forty-three years since the UK acceded to the European Union, a large body of case law has developed in the Court of Justice of the EU and national courts dealing with parallel trade of pharmaceuticals within the EU. A recent decision in the English Courts, Flynn Pharma v Drugsrus Limited and Tenolol Limited [2015] EWHC 2759 (Ch), has added to that body of case law. It considers parallel imports in an commercially important context: the divestment in one member state of the EU by a resear...
EVERSHEDS.COM
READ MORE

Medicare and its beneficiaries could have saved an estimated $17.7 billion over a seven-year period on generic versions of older medicines instead of paying for newer, chemically similar but more expensive brand-name drugs, according to a study published in the Annals of Internal Medicine last month. The study was conducted as part of the Collaboration for Research Integrity and Transparency at Yale Law School, funded by the Laura and John Arnold Foundation. The intent was to estimate the potent...

READ MORE

After filings in the US and Japan, Bayer has submitted data to European regulators for its prostate cancer drug darolutamide. This is the third filing in two weeks for darolutamide, meaning that the drug is now under review with regulators from three of the largest drug markets in the world. Bayer has filed results of the phase 3 ARAMIS study, testing darolutamide in patients with non-metastatic castration-resistant prostate cancer, with regulators from the European Medicines Agency (EMA). The r...

READ MORE

It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs. "The drug is reducing the ability of cancer cells to create a distant microenvironment where they can thrive," said Dr. Ali S. Arbab, leader of the Tumor Angiogenesis Initiative at the Georgia Cancer Center and a professor in the Department of Bioche...

READ MORE

AstraZeneca continues to make the case for its Farxiga diabetes drug, highlighting a cardiology analysis that it hopes will convince more doctors to prescribe it in a highly competitive market. Farxiga (dapagliflozin) is AZ’s fifth biggest-selling drug, making up around 7% of product sales. Last year’s sales of nearly $1.4 billion were a 30% year-on-year increase, but its main US patent is set to expire next year and it's EU patent in 2023. So AZ is trying to make the most of the...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...